Robert Loberg is a global healthcare executive with experience across a range of R&D and commercial activities at both BioPharma and Diagnostics companies. His experience in development, regulatory approval, and market access has led to a record of delivering strategies that support a broad portfolio of pharmaceutical and diagnostic products. With 40 peer-reviewed publications and considerable hands-on lab work, Robert has demonstrated a passion for Biomarker research and its applications in cancer therapeutics.  Robert currently serves as Lifecycle leader for the Oncology & Genetics team a...read more